Novel transcriptional regulation of the GAP promoter in Pichia pastoris towards high expression of heterologous proteins
Microbial Cell Factories · 2024
DOI: 10.1186/s12934-024-02435-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Cell Factories, 2024. Verfasst von Xiangna Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine, Jinan University, Guangzhou City, 510632, Guangdong Province, China. Hauptthemen laut MEDLINE: Promoter Regions, Genetic, Gene Expression Regulation, Fungal, Transcription Factors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Pichia pastoris ( Komagataella phaffii ) is a promising production host, but the usage of methanol limits its application in the medicine and food industries.
Results
To improve the constitutive expression of heterologous proteins in P. pastoris, four new potential transcription regulators (Loc1p, Msn2p, Gsm1p, Hot1p) of the glyceraldehyde triphosphate dehydrogenase promoter (pGAP) were revealed in this study by using cellulase E4 as reporter gene. On this basis, a series of P. pastoris strains with knockout or overexpression of transcription factors were constructed and the deletion of transcription factor binding sites on pGAP was confirmed. The results showed that Loc1p and Msn2p can inhibit the activity of pGAP, while Gsm1p and Hot1p can enhance the activity of pGAP; Loc1p, Gsm1p and Hot1p can bind directly to pGAP, while Msn2p must be treated to expose the C-terminal domain to bind to pGAP. Moreover, manipulating a single transcription factor led to a 0.96-fold to 2.43-fold increase in xylanase expression. In another model protein, aflatoxin oxidase, knocking out Loc1 based on AFO-∆Msn2 strain resulted in a 0.63-fold to 1.4-fold increase in expression. It can be demonstrated that the combined use of transcription factors can further improve the expression of exogenous proteins in P. pastoris .
Conclusion
These findings will contribute to the construction of pGAP-based P. pastoris systems towards high expression of heterologous proteins, hence improving the application potential of yeast.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedicine, Jinan University, Guangzhou City, 510632, Guangdong Province, China.
- National Engineering Research Center of Genetic Medicine, Jinan University, Guangzhou City, 510632, Guangdong Province, China.
- Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou City, 510632, Guangdong Province, China.
- Department of Bioengineering, Jinan University, Guangzhou City, 510632, Guangdong Province, China.
- Institute of Biomedicine, Jinan University, Guangzhou City, 510632, Guangdong Province, China. tdsyao@jnu.edu.cn.
- National Engineering Research Center of Genetic Medicine, Jinan University, Guangzhou City, 510632, Guangdong Province, China. tdsyao@jnu.edu.cn.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Lin, X., Ding, W., Zheng, S., Wu, L., Chen, X., Xie, C., Liu, D., & Yao, D. (2024). Novel transcriptional regulation of the GAP promoter in Pichia pastoris towards high expression of heterologous proteins. Microbial Cell Factories. https://doi.org/10.1186/s12934-024-02435-9
Vancouver
Lin X, Ding W, Zheng S, Wu L, Chen X, Xie C, et al. Novel transcriptional regulation of the GAP promoter in Pichia pastoris towards high expression of heterologous proteins. Microbial Cell Factories. 2024. doi:10.1186/s12934-024-02435-9
BibTeX
@article{Lin2024,
author = {Lin, Xiangna and Ding, Weiqiu and Zheng, Shaoyan and Wu, Lianna and Chen, Xue and Xie, Chunfang and Liu, Daling and Yao, Dongsheng},
title = {Novel transcriptional regulation of the GAP promoter in Pichia pastoris towards high expression of heterologous proteins},
journal = {Microbial Cell Factories},
year = {2024},
doi = {10.1186/s12934-024-02435-9}
}
EUVIMED